Longevity peptides, chosen for your biology
“Longevity peptides” is really a short list of compounds — rapamycin, urolithin A, methylene blue, oxytocin — each studied for a distinct pathway of aging. None is a magic molecule. The value is in matching the right one to your labs and goals, prescribed and monitored by a clinician — not chosen from a trend.
- Clinician-prescribed
- Lab-monitored
- Personalized dosing
- HSA/FSA eligible
The idea
Which peptides are actually studied for longevity?
Every protocol comes with real clinical care — not a compound in the mail.
40
+
Biomarkers reviewed
Your labs are mapped to the protocol most likely to fit your biology.
4
Distinct pathways
Mitophagy, autophagy, mitochondrial energy and the oxytocin stress axis.
100
%
Clinician-reviewed
Prescription protocols are written by licensed clinicians and dispensed by certified pharmacies.
1
Protocol, built for you
Dosing is personalized and adjusted over time as your biomarkers change.
The research behind the mechanisms
Peer-reviewed studies on the pathways these compounds act on. Much of this work is mechanistic or in animal models — human longevity evidence is still emerging.
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice (Nature, 2009)
Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents (Nature Medicine, 2016)
Methylene blue improves brain oxidative metabolism and memory retention in rats (Pharmacol Biochem Behav, 2004)
Oxytocin in the cardiovascular responses to stress (J Physiol Pharmacol, 2008)
Common questions
“Longevity peptides” is a loose, popular label for a small set of compounds studied for the biology of aging — some are true peptides (short chains of amino acids, like the neuropeptide oxytocin), others are small molecules often grouped with them (rapamycin, methylene blue, urolithin A). Each is tied to a specific pathway, such as mTOR/autophagy, mitochondrial energy or mitophagy. At Healthspan they are prescribed or recommended and monitored by licensed clinicians.
Current protocols include rapamycin (an mTOR modulator), the Mitophagy Formula (urolithin A), methylene blue, and oxytocin (a neuropeptide, offered as a nasal spray or troche), alongside a Longevity Optimization membership that adds lab testing and biological-age tracking. A clinician determines which, if any, is appropriate for you.
The strongest lifespan data — for example rapamycin and urolithin A — comes from animal models and cell studies, not from long-term human longevity trials, which largely do not exist yet. That is why we describe what each compound is studied for rather than promising outcomes, and why every protocol is clinician-gated and monitored.
The prescription compounds — for example rapamycin, methylene blue and oxytocin — require a licensed clinician to review your intake and labs and decide whether they are appropriate. Urolithin A (the Mitophagy Formula) is offered as a supplement. Nothing is dispensed without clinical review.
Each compound has its own risk profile and is used off-label for longevity, so suitability is decided individually by a clinician after reviewing your history and labs — not assumed. Protocols include ongoing lab monitoring and dose adjustment, and known side effects and contraindications are reviewed with you before you start.
That is what the assessment is for. It maps your biomarkers, history and goals to the protocol most likely to fit, and a licensed clinician makes the final recommendation — which may be a peptide, another longevity compound, a broader program, or none.
Yes. Protocols include physician oversight and lab monitoring, with retesting so dosing can be adjusted as your biomarkers change. Membership options add biological-age tracking and an ongoing care team.
“Longevity peptides” is a loose, popular label for a small set of compounds studied for the biology of aging — some are true peptides (short chains of amino acids, like the neuropeptide oxytocin), others are small molecules often grouped with them (rapamycin, methylene blue, urolithin A). Each is tied to a specific pathway, such as mTOR/autophagy, mitochondrial energy or mitophagy. At Healthspan they are prescribed or recommended and monitored by licensed clinicians.
Current protocols include rapamycin (an mTOR modulator), the Mitophagy Formula (urolithin A), methylene blue, and oxytocin (a neuropeptide, offered as a nasal spray or troche), alongside a Longevity Optimization membership that adds lab testing and biological-age tracking. A clinician determines which, if any, is appropriate for you.
The strongest lifespan data — for example rapamycin and urolithin A — comes from animal models and cell studies, not from long-term human longevity trials, which largely do not exist yet. That is why we describe what each compound is studied for rather than promising outcomes, and why every protocol is clinician-gated and monitored.
The prescription compounds — for example rapamycin, methylene blue and oxytocin — require a licensed clinician to review your intake and labs and decide whether they are appropriate. Urolithin A (the Mitophagy Formula) is offered as a supplement. Nothing is dispensed without clinical review.
Each compound has its own risk profile and is used off-label for longevity, so suitability is decided individually by a clinician after reviewing your history and labs — not assumed. Protocols include ongoing lab monitoring and dose adjustment, and known side effects and contraindications are reviewed with you before you start.
That is what the assessment is for. It maps your biomarkers, history and goals to the protocol most likely to fit, and a licensed clinician makes the final recommendation — which may be a peptide, another longevity compound, a broader program, or none.
Yes. Protocols include physician oversight and lab monitoring, with retesting so dosing can be adjusted as your biomarkers change. Membership options add biological-age tracking and an ongoing care team.
Your protocol
- for energy
- for stress
- for you
built around you
Let your biology decide
()
The best peptide is the one matched to your numbers. Take the 2-minute assessment and get a clinician-built plan.
HSA/FSA eligible · Cancel anytime
The peptides and longevity compounds described here are prescribed or recommended only after clinical review, and several are used off-label for longevity. Human longevity evidence for most of them is still emerging, and much of the cited research is mechanistic or in animal models. A licensed clinician determines whether any protocol is appropriate for you. This page is educational and not medical advice; individual results vary.